Pons Mònica, Núñez Alexa, Esquinas Cristina, Torres-Durán María, Rodríguez-Hermosa Juan Luis, Calle Myriam, Tubio-Pérez Ramón, Belmonte Irene, Rodríguez-Frías Francisco, Rodríguez Esther, Genescà Joan, Miravitlles Marc, Barrecheguren Miriam
Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
J Clin Med. 2021 Apr 16;10(8):1724. doi: 10.3390/jcm10081724.
Screening of liver disease in alpha-1 antitrypsin deficiency (AATD) is usually carried out with liver enzymes, with low sensitivity. We conducted a multicenter cross-sectional study aiming to describe the utility of transient elastography for the identification of liver disease in patients with AATD. A total of 148 AATD patients were included. Among these, 54.7% were PiZZ and 45.3% were heterozygous for the Z allele. Between 4.9% and 16.5% of patients had abnormal liver enzymes, without differences among genotypes. Liver stiffness measurement (LSM) was significantly higher in PiZZ individuals than in heterozygous Z (5.6 vs. 4.6 kPa; = 0.001). In total, in 8 (5%) individuals LSM was >7.5 kPa, considered significant liver fibrosis, and ≥10 kPa in 3 (1.9%) all being Pi*ZZ. Elevated liver enzymes were more frequently observed in patients with LSM > 7.5 kPa, but in 5 out of 8 of these patients all liver enzymes were within normal range. In patients with AATD, the presence of abnormal liver enzymes is frequent; however, most of these patients do not present significant liver fibrosis. Transient elastography can help to identify patients with liver fibrosis even with normal liver enzymes and should be performed in all Z-allele carriers to screen for liver disease.
α-1抗胰蛋白酶缺乏症(AATD)患者的肝病筛查通常采用肝酶检测,但敏感性较低。我们开展了一项多中心横断面研究,旨在描述瞬时弹性成像在识别AATD患者肝病中的应用价值。共纳入148例AATD患者。其中,54.7%为PiZZ型,45.3%为Z等位基因杂合子。4.9%至16.5%的患者肝酶异常,各基因型之间无差异。PiZZ个体的肝脏硬度测量值(LSM)显著高于Z等位基因杂合子个体(5.6对4.6 kPa;P = 0.001)。共有8例(5%)个体的LSM>7.5 kPa,被认为有显著肝纤维化,3例(1.9%)LSM≥10 kPa,均为Pi*ZZ型。LSM>7.5 kPa的患者更常出现肝酶升高,但其中8例患者中有5例所有肝酶均在正常范围内。在AATD患者中,肝酶异常很常见;然而,这些患者大多数没有显著肝纤维化。即使肝酶正常,瞬时弹性成像也有助于识别肝纤维化患者,所有Z等位基因携带者均应进行该检查以筛查肝病。